Gyeonggi-do, South Korea

Heun Soo Kang

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2019 - 2020)
  • Seoul, KR (2022 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Heun Soo Kang: Innovator in Therapeutic Cell Quality Improvement

Introduction

Heun Soo Kang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of therapeutic cell quality improvement, holding a total of 5 patents. His work focuses on innovative methods that enhance the quality of therapeutic cells through advanced monitoring techniques.

Latest Patents

Among his latest patents, Heun Soo Kang has developed a method for improving the quality of therapeutic cells through real-time glutathione measurement. This invention relates to a technique that allows for the monitoring of glutathione levels in therapeutic cells, thereby ensuring their quality. Additionally, he has created a method for measuring the quality of therapeutic cells through real-time glutathione monitoring, which provides a reliable way to assess cell quality during therapeutic applications.

Career Highlights

Heun Soo Kang has worked with several companies throughout his career, including Cell2in, Inc. and Snur & Db Foundation. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in therapeutic cell technologies.

Collaborations

He has collaborated with notable coworkers such as Ki Hang Choi and Hye Mi Kim, further enhancing the impact of his work in the field.

Conclusion

Heun Soo Kang's contributions to the field of therapeutic cell quality improvement are significant and impactful. His innovative methods and collaborations continue to advance the understanding and application of therapeutic cells in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…